Post Market Clinical Follow-up Study for the Pamira ICD Lead Family

A trial with no phase registered on ClinicalTrials.gov. The registry status is completed. It enrolled 221 participants.

Also called NCT05621187

  • Study
  • In this atlas

Overview

Design
Interventional study; allocation not applicable; no masking; primary purpose other
Phase
Not applicable
Enrolled
  • 221 participants (enrolled count) (from the registry)
Sponsor
Registry
  • NCT NCT05621187
Started
(actual) (from the registry)
Primary completion
(actual) (from the registry)
Completion
(actual) (from the registry)
Countries
Australia, Austria, Belgium, Germany, Hungary, Israel, Latvia, Slovakia (from the registry)
Registry status
  • Completed (from the registry)

Technical summary

Registry record NCT05621187. Allocation not applicable; no masking; primary purpose other. Start 2022-11-30 (actual); primary completion 2025-01-20 (actual). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
Post Market Clinical Follow-up Study for the Pamira ICD Lead Family
Condition
Heart Failure
Condition
Tachyarrhythmia
Intervention (Device)
Pamira ICD lead family
Lead sponsor
Biotronik SE & Co. KG (class: industry)

Record details

Record id
cardio:ct-nct05621187
Content hash
76d5d842d026e19bd1c06fec3c23d77cb173e8c5c54ed343ddb00c0e038c784c